pharmaceutical and non-pharmaceutical modalities / federal law / psychiatric management / ancillary services / /
MedicalCondition
characteristic withdrawal syndrome / diseases / drug class specific withdrawal syndrome / cocaine-induced depression / withdrawal symptoms / comorbid psychiatric disorders / chronic / neurobiologic disease / /
MedicalTreatment
counseling / drug therapy / psychotherapy / /
Organization
Arizona Medical Board / American Psychiatric Association / FDA / Diagnostic and Statistical Manual of Mental Disorders / office of Pharmacologic and Alternative Therapies / /
Suboxone (buprenorphine/naloxone) was approved in 2002 for office based opioid- assisted treatment of addiction, by physicians